collaboration
Korean AI Pathology Startup Lunit Nabs $26M Investment from Guardant Health; Plans Collaboration
Having closed a Series C funding round, the firm is completing clinical validation, and will collaborate with Guardant to develop new precision oncology products.
Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration
Saga will use its digital PCR-based SagaSafe assays to analyze hundreds of clinical tissue samples from the TRACERx and PEACE studies.
EchelonDx, Oncocyte to Develop Software Supporting Commercial Diagnostics Expansion
The two firms are developing an analytical software solution to help Oncocyte scale its commercial oncology test business to a global scale.
Vela Diagnostics, National Cancer Center of Singapore to Develop CDx for EGFR-TKI Therapies
Vela Diagnostics and NCCS will evaluate the efficacy of the assay in a clinical trial to test the response of patients to EGFR-TKI therapies.
Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer
The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients.